Ara-Augusta Clinic Llc
NPI #1194772947

End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility located in Augusta, GA

0
1000 Telfair St
Augusta, GA 30901-2208
(706) 774-0130

About

Ara-Augusta Clinic Llc is a End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility (taxonomy code 261QE0700X) located in Augusta, Georgia. Ara-Augusta Clinic Llc's NPI Number is #1194772947 and has been listed in the NPI registry for 18 years. Ara-Augusta Clinic Llc's practice location is listed as: 1000 Telfair St Augusta, GA 30901-2208 and can be reached via phone at (706) 774-0130.

Contact Information

NPI Number
1194772947
Website
Not provided

Address
1000 Telfair St
Augusta, GA 30901-2208

Specialties


Business Information

Sole-Proprietor?
Not Available
Is Sub-Organization?
No
Parent Organization Name
Not Applicable

About This listing

Last Updated
3/16/2017 7 years ago
Date Added
5/27/2006 18 years ago
Viewed On
10/13/2024 just now

End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility Taxonomy Info

The taxonomy code for Ara-Augusta Clinic Llc's main specialty, End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility, is 261QE0700X.

Click here to see more information about this taxonomy and find other providers that specialize in End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility

Ratings

Be the first to rate Ara-Augusta Clinic Llc

Overall
Professionalism
Facilities
Availability
Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.


Health Care Providers Nearby











Success

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.